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ABSTRACT
The chemokine receptor CXCR4 is expressed by CD34 hematopoietic stem/progenitor cells (HSC/HPC).
Several investigators have suggested that expression of CXCR4 may be an important characteristic of HSC/
HPC. We studied the dynamic expression of CXCR4 during growth factor–induced mobilization of HSC in a
clinically relevant nonhuman primate model, Papio anubis (baboons). We evaluated whether CXCR4 expres-
sion in HSC/HPC varies during steady-state hematopoiesis as well as during growth factor–induced mobili-
zation. Peripheral blood stem cells from 5 baboons were mobilized with growth factors. During mobilization,
there was a consistent stepwise increase in the proportion of peripheral blood CD34 cells that were CXCR4.
The highest number of CD34CXCR4 cells appeared in the peripheral blood at the same time as the
maximum number of assayable colony-forming cells. The cloning efficiency of the CD34CXCR4 population
was 3-fold greater than that of CD34CXCR4 cells, and the frequency of cobblestone area-forming cells was
6 times higher in the CD34CXCR4 population in comparison to CD34CXCR4 cells. Furthermore, the
most quiescent CD34 cells isolated on the basis of low Hoechst 33342 (Ho) and rhodamine 123 (Rho) staining
(HoLow/RhoLow) were highly enriched in the CXCR4Low/ cell population. Ex vivo incubation of mobilized
peripheral blood CD34 cells with growth factors for 40 hours resulted in increasing numbers of cells
expressing CXCR4. Peripheral blood stem cell grafts containing CD34 cells that consisted of predominantly
CXCR4 cells were able to rapidly engraft lethally irradiated baboons. Because the overwhelming number of
CD34 cells within the mobilized peripheral blood grafts were CXCR4 and were capable of rescuing lethally
irradiated baboons, it seems unlikely that the expression of CXCR4 in vitro is an absolute requirement for HSC
homing and engraftment. In summary, our data suggest the dynamic nature of CXCR4 expression on CD34
cells during growth factor–induced HSC/HPC mobilization. In addition, our data indicate that the lack of
CXCR4 expression is possibly a characteristic of relatively more primitive HSC/HPC characterized by a higher
proliferative capacity.
© 2004 American Society for Blood and Marrow Transplantation
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Hematopoietic stem/progenitor cells (HSC/HPC)
resent within the bone marrow (BM) are capable of
aintaining continuous production of mature blood
ells throughout the life span of an animal [1]. During
ntogeny, hematopoiesis occurs at different sites, with
evelopmental stage-speciﬁc shifts from the yolk sac to
he aorta-gonad-mesonephros region, liver, and spleen
nd then to the BM and thymus [2]. Mechanisms or-
hestrating these shifts in hematopoietic activity are not s
B&MTell understood. The migratory ability of adult human
SC/HPC is highlighted during HSC transplantation,
uring which HSC/HPC seed and sustain donor-de-
ived hematopoiesis in the BM of recipient after intra-
enous (IV) infusion [3]. In addition, recombinant hu-
an granulocyte colony-stimulating factor (rhG-CSF)
dministration results in the mobilization of HSC/HPC
romBM to the peripheral blood (PB) [4,5]. A number of
dhesive interactions between progenitor cells and BM
tromal cells or extracellular matrix proteins have been
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6ypothesized to play a role in HSC/HPC trafﬁcking [6].
he most compelling model for disruption of the nor-
al processes governing HSC/HPC localization is pro-
ided by mice genetically engineered to be deﬁcient in
he expression of the chemokine receptor CXCR4 or its
igand, SDF-1 [7,8]. These animals are characterized by
ormal hematopoiesis within the liver but defective de-
nitive hematopoiesis within the marrow of the devel-
ping rodents of this phenotype [7,8]. Several studies
ave suggested the variability of CXCR4 expression on
obilized PB (MPB), and this contradicts direct corre-
ation of CXCR4 expression on HSC/HPC with hom-
ng and engraftment [9-11]. Similarly, cell-surface phe-
otype CD34, which is widely used to enumerate and
nrich HSC/HPC, has been shown to vary with devel-
pmental stage [12]. Furthermore, Rosu-Myles et al.
13] and others have recently documented that both the
XCR4 and the CXCR4 population of human HSC
rom different tissues, including cord blood, were capa-
le of hematopoietic engraftment when transplanted
nto nonobese diabetic/severe combined immunodeﬁ-
iency (NOD/SCID) mice, indicating that surface ex-
ression of CXCR4 detected in vitro is not an absolute
equirement for HSC homing [13,14]. Diminished
XCR4 expression by MPB CD34 cells was attributed
o the internalization of the CXCR4 molecule, which
an be quickly re-expressed upon exposure to growth
actors [14]. Despite the variability of CXCR4 expression
n human MPB CD34 cells, MPB grafts have been
ssociated with more rapid hematopoietic engraftment
15]. In summary, whether the expression of CXCR4 is
characteristic of HSC/HPC remains unclear. Because
mportant functional differences are known to exist be-
ween HSC/HPC of large animals and rodents [16-20],
e attempted to study the dynamic changes of expres-
ion of CXCR4 on CD34 cells during growth factor–
nduced (recombinant human stem cell factor [SCF] and
-CSF or G-CSF alone) mobilization of HSC/HPC.
uring growth factor administration, we studied se-
uentially the distribution of CXCR4 cells in the BM
nd in the PB. In addition, we investigated whether there
s a functional difference between CD34CXCR4 cells
nd CD34CXCR4 cells during steady-state hemato-
oiesis, as well as in MPB.
ATERIALS AND METHODS
nimals
Five healthy juvenile baboons (Papio anubis)
eighing 9 to 10 kg were used for this study. The
nimals were housed under conditions approved by
he Association for the Assessment and Accreditation
f Laboratory Animal Care. The studies were per-
ormed under protocols approved by the Animal Care
ommittee of the University of Illinois at Chicago.
nimals were provided with water, biscuits, and fruits
hroughout the study. B
82eukapheresis
Leukapheresis was conducted after 5 to 8 days of
rowth factor (rhG-CSF alone or rhG-CSF and re-
ombinant human SCF) treatment, depending on the
otal PB white cell counts, by using previously de-
cribed protocols with little modiﬁcation [16,21]. The
nimal’s peripheral veins were cannulated with an 18-
auge Angiocath or a 16-gauge Teﬂon (DuPont, Wil-
ington, DE) catheter after the animal was anesthe-
ized.
A Cobe Spectra (Cobe, Lakewood, CO) leuka-
heresis unit was used to collect the stem cell grafts.
eukapheresis was performed at a rate of 40 mL/min
nd a bowl speed of 900 to 950 rpm for 4 hours. The
eukaphereses were performed with animals under
etamine sedation (10 mg/kg body weight intramus-
ularly) followed by thiopental (25 mg/kg body
eight) induction and general oral endotracheal anes-
hesia (isoﬂurane 1%-2%). A Cobe Spectra leuka-
heresis unit was primed with approximately 180 mL
f irradiated whole blood obtained from another
BO-compatible baboon blood donor. Venous access
or both the draw and return lines was obtained by a
urgical cut-down of the right femoral vein, where a
ouble-lumen 7F pediatric hemodialysis catheter
Medcomp, Harleysville, PA) was inserted. Before leu-
apheresis, each animal was anticoagulated with hep-
rin (50 U/kg) administered as an IV bolus after can-
ulation, followed by a continuous IV infusion at a
ate of 10 U/kg/h). Acid citrate dextrose (Baxter/Fen-
al, Deerﬁeld, IL) was administered via continuous
V infusion at the rate of 1 mL/25 mL of whole blood
ntering the machine. Flow rates of approximately 20
o 25 mL/min were obtained to process approximately
blood volumes during the period of leukapheresis.
he leukapheresis product was collected into a single
lastic blood collection bag (Baxter) containing 20 mL
f acid citrate dextrose.
M Collections
BM samples were obtained from the iliac crests of
nimals after ketamine (10 mg/kg) and xylazine (1
g/kg) sedation. The collection and separation of BM
ells, PB cells, and cells within the leukapheresis prod-
ct were performed as previously described [16]. The
eparinized BM, PB, or LPs were diluted 1:8 in phos-
hate-buffered saline, and the mononuclear cell
MNC) fraction was obtained by centrifugation over
0% Percoll (Pharmacia, Uppsala, Sweden) at 500g
or 30 minutes at room temperature.
election of CD34 Cells and Staining for CXCR4
A MNC fraction obtained by density gradient
entrifugation was selected for CD34 cells by
agnetic activated cell sorting (MACS; Miltenyi
iotec, Auburn, CA) by means of mouse immuno-
g
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CXCR4 Negative Cells in Mobilized Peripheral Blood
Blobulin (Ig)M monoclonal antibody (mAb) 12-8
CD34; a gift of Dr. Robert G. Andrews, Fred
utchinson Cancer Research Center, Seattle, WA)
nd anti-mouse IgM microbeads (Miltenyi Biotec),
s described previously [16]. The positively selected
ells were checked for purity by using donkey anti-
at IgG, an antibody against the isotype of mi-
robeads used for CD34 selection with the MACS
ystem. Anti-CXCR4 (clone 12G5; Pharmingen,
an Diego, CA) or a matched isotype control was
sed to detect CXCR4 expression on both PB and
M by using either a FACSVantage or a FACSCali-
ur (Becton Dickinson, San Diego, CA). To con-
rm that the mAb against human CXCR4 cross-
eact with baboon blood cells, anti-CXCR4 mAb
as titrated using 0 to 60 L per test on baboon PB
r BM cells and compared with that of human PB
NCs. When 20 L of the anti-CXCR4 was used,
he percentage of CXCR4 cells detectable among
D34 cells in baboon BM was comparable to that
f CD34 cells that were stained to CXCR4 in the
uman PB (data not shown). In some experiments,
nother mAb, K6.1 (gift of the Naval Medical Re-
earch Institute, Bethesda, MD), a murine IgG2a,
hich also recognizes the analogous baboon CD34
pitope, was also used. Fluorescence-activated cell
orting was performed with FACSVantage. Sub-
opulations of CD34 cells were obtained on the
asis of the presence or absence of CXCR4 expres-
ion. These cells were subsequently used for func-
ional studies. The photomultiplier tube voltages
ere adjusted to compensate for the overlap of the
uorescein isothiocyanate and phycoerythrin emis-
ion spectra.
oechst/Rhodamine Staining
The ﬂuorescent dyes Hoechst 33342 (Ho) and
hodamine 123 (Rho) (Molecular Probes, Eugene,
R) were used to obtain subpopulations of CD34
ells enriched for primitive hematopoietic progeni-
ors, as described previously [16]. CD34 cells were
uspended at the concentration of 106/mL in 0.1
g/mL Rho and incubated in the dark for 30 minutes
t 37°C. The cells were then centrifuged and resus-
ended in 10 mol/L Ho and incubated at 37°C for 1
our in the dark. The cells were washed twice in
ce-cold phosphate-buffered saline containing 0.2%
ovine serum albumin (Sigma Chemical Co., St.
ouis, MO) and kept on ice until sorting. Cell sorting
as performed with a FACSVantage. Green ﬂuores-
ent pulses (Rho) were collected through a ﬂuorescein
sothiocyanate 530-nm ﬁlter with a bandwidth of 15
m. UV emissions (Ho) were reﬂected by a 440 di-
hroic long-pass mirror and collected by a 424DF44
lter. Cells were sorted at a rate of 2000/s and col- b
B&MTected in polypropylene tubes in media containing
0% fetal bovine serum (FBS; Hyclone, Logan, UT).
CD34 cells that had the least amount of DNA
HoLow) were further arbitrarily subdivided into Rho
ow (RhoLow), Rho intermediate (RhoInt), and Rho
igh (RhoHi) populations, as previously described
16]. Then CD34 cells were sorted for HoLow/
hoLow cells. In addition, after Ho/Rho staining, cells
ere re-stained for CXCR4 and its matched isotype
ontrol.
olony-Forming Cell Assays
Colony-forming cells (CFC) were assayed under
tandard conditions in semisolid media as previously
escribed [16]. Brieﬂy, 1  103 to 2  103 cells were
lated in replicate cultures containing 1 mL of Iscove
odiﬁed Dulbecco medium (IMDM) with 1.1%
ethylcellulose, 30% FBS, and 5  105 mol/L
-mercaptoethanol (Methocult; Stem Cell Technolo-
ies, Vancouver, Canada), to which a cocktail of
rowth factors including 100 ng/mL recombinant hu-
an SCF, 100 ng/mL Flt3 ligand, 10 ng/mL inter-
eukin (IL)–3, 10 ng/mL IL-6, 10 ng/mL granulocyte-
acrophage colony-stimulating factor (all purchased
rom R&D Systems, Minneapolis, MN), and 5 U/mL
f erythropoietin (a gift of Amgen, Inc.) were added.
he cells were plated onto 35-mm tissue culture
ishes (Costar, Corning Inc., Corning, NY), and after
4 days of incubation at 37°C in a 100% humidiﬁed
tmosphere containing 5% CO2, the colonies were
cored with an inverted microscope by using standard
riteria.
obblestone Area-Forming Cell Assays
The ability of primitive HSC/HPC to form cob-
lestone areas (CA) in long-term marrow cultures
as been used as an in vitro surrogate HSC assay
21,22]. Baboon cobblestone area-forming cells
CAFC) give rise to undifferentiated, uniformly
ized, round refractile cells arranged in a compact
anner when cocultured with murine stromal ﬁbro-
lasts in the presence of human cytokines for 5
eeks [16]. BM CD34, CD34CXCR4, and
D34CXCR4 cells were plated in limiting dilu-
ion in ﬂat-bottomed 96-well plates (Costar, Corn-
ng Inc.) onto conﬂuent, irradiated (7000 cGy)
onolayers of the murine stromal ﬁbroblast line
2-10B4 (a gift of C. Eaves, Vancouver, Canada).
ach well contained 200 L of a 50:50 mixture of
MDM and RPMI with 10% FBS. A cocktail of
rowth factors including 100 ng/mL SCF, 100
g/mL leukemia inhibitory factor (a gift of Amgen),
0 ng/mL IL-3, 50 ng/mL IL-6, and 50 ng/mL
ranulocyte-macrophage colony-stimulating factor
as added to these assays. The cytokine cocktail has
een previously shown by our laboratory to be op-
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6imal for the development of baboon CA (data not
hown). The cultures were fed weekly by replace-
ent of half of the culture volume with fresh me-
ium containing the above cytokines at 2 times the
reviously deﬁned concentration. After 5 weeks of
ulture in a humidiﬁed incubator at 37°C contain-
ng 5% CO2, the number of CA was scored with an
nverted microscope by using standard criteria [23].
he CAFC frequency was computed by using min-
mization of  by regression to the cell number at
hich 37% of wells were negative for CA forma-
ion, with 95% statistical precision [21–23].
x Vivo Culture of MPB CD34 Cells
Baboon CD34 cells enriched by MACS column
ere cultured in the presence of SCF (100 ng/mL)
nd G-CSF (20 ng/mL) supplemented with 10% FBS
n IMDM. After 40 hours of incubation at 37°C in 5%
O2, cells were harvested and stained for CD34 and
XCR4. The cells were acquired by FACSCalibur
nd analyzed with Cell Quest software (Becton Dick-
nson). At least 10 000 events were acquired for anal-
sis.
eripheral Blood Stem Cell Transplantation
Two weeks before transplantation, recipient animals
ere ﬁtted with jackets and placed on a tether system, as
reviously described [20]. One week later, central venous
atheters were placed in the jugular and femoral veins by
urgical cut-down. Four days before transplantation, a
yeloablative dose of total body irradiation (TBI) was
elivered by a Varian Clinac 2100EX linear accelerator
Varian Medical System, Palo Alto, CA) by using a
-MV photon beam through 2 lateral portals in 8 frac-
ions twice daily from both sides of the body at a total
ose of 1000 cGy (125 cGy  2/day  4) 24 hours
efore stem cell infusion. After completion of TBI (day
), the animals were infused with cryopreserved periph-
ral blood stem cell (PBSC) or BM grafts.
tatistical Analysis
Statistical signiﬁcance was determined by paired
tudent t tests with signiﬁcance at P  .05.
ESULTS
umber of CXCR4 Cells in the PB after Growth
actor Administration
To investigate the role of CXCR4 in mobilization of
SC/HPC, the kinetics of the appearance of CXCR4
ells and CFCs were studied in MNC obtained from PB
fter growth factor administration to baboons. We stud-
ed the kinetics of CXCR4 cells and CFC number in
he PB for 20 days after growth factor administration.
CF was administered on days 1 to 3, after which G- c
84SF was injected in combination with SCF on days 4 to
. The percentage of CXCR4 cells in the PB decreased
radually during the course of growth factor administra-
ion (Figure 1). The percentage of CXCR4 and the
loning efﬁciency of CFC (mean number of colonies/
umber of cells plated  100) in the PB of 2 animals is
lotted in Figure 1. On day 7 and day 10 after growth
actor administration, the number of CXCR4 cells in
B MNC of the 2 experimental animals decreased to
heir lowest levels (Figure 1A). The decline of CXCR4
ells in the PB was inversely related to the increases in
he number of PB CFC (Figure 1B). The number of
XCR4 cells started to increase after 8 days of growth
actor administration, whereas the number of CFC was
educed to baseline levels within 20 days from the start of
rowth factor administration. To further investigate the
ssociation between the numbers of CXCR4 cells and
he numbers of CFC, we studied the kinetics of alter-
tion of CXCR4 and CFC in the PB before and after
rowth factor administration in 3 additional animals.
uring steady state, 67.66%  6.53% of MNC in the
B were CXCR4, but after growth factor administra-
ion, the number of CXCR4 cells in the PB declined to
4.4% 3.5% (P .05; Table 1). However, the cloning
fﬁciency of CFC in the PB MNC before growth factor
dministration was 1.2%  1.3% (P  .05), which in-
igure 1. Expression of CXCR4 by PB MNC is inversely related to
he number of PB CFC after growth factor–induced mobilization.
uring administration of recombinant human stem cell factor and
hG-CSF to juvenile baboons, PB MNC were analyzed at different
ime points to determine the kinetics of the appearance of CXCR4
ells by ﬂow cytometry (A), as well as assayable progenitor cells in
B MNC (B). The kinetics of CXCR4 cells and the number of
FC are plotted from 2 different baboons (PA6660 and PA5909).reased to 8.1% 1.3% after growth factor administra-
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CXCR4 Negative Cells in Mobilized Peripheral Blood
Bion (Table 1). It was clear from these ﬁndings that the
umber of assayable CFC increased when the number of
XCR4 cells declined in the PB. To examine which
ell populations may be responsible for the increase in
FC after growth factor administration, we analyzed
D34 cells from PB both before and after growth
actor administration. On average, 32%  4.3% of the
D34 cells were CXCR4 in the PB of steady-state
nimals (day 0; Table 2). After growth factor adminis-
ration, the percentage of CD34 that were CXCR4
ncreased to 76%  3.51% (P  .05; n  5; Table 2).
teady-state BM had 41.0% 3.67% CD34CXCR4
ells, which increased to 51%  8.61% cells after
rowth factor administration. This modest increase in
D34CXCR4 cells in the marrow was not statisti-
ally signiﬁcant (P  .375; n  5; Table 2).
bsolute Number of CD34CXCR4 and
D34CXCR4 Cells in the MPB
Next we examined the absolute number of
D34CXCR4 cells in the PB in response to growth
actor administration. Before growth factor administra-
ion, there were 2-fold more CD34CXCR4 cells than
D34CXCR4 cells in the PB (Table 3). Both
D34CXCR4 and CD34CXCR4 cells gradually
able 1. Increase in Peripheral Blood Hematopoietic Progenitor Cells Is
dministration
Animal
CFC Cloning Efficiency
PB M
A5909* 1.4
A6660* 1.4 1
A6661† 0.8 1
A6243† ND
A5957† ND
ean  SE 1.2  1.3‡ 8.12
loning efﬁciency indicates the number of colonies obtained out o
SCF and G-CSF were used to mobilize HSC/HPC in these anim
G-CSF alone was used to mobilize HSC/HPC; PB indicates pe
leukapheresis.
P  .0005; §P  .025, paired t test.
able 2. The Percentage of CD34CXCR4 Cells Is Altered in PB
ut Not in BM after Growth Factor Administration
Tissues
No. Baboons
Studied CD34CXCR4
B 3 32.3  4.63*
PB 5 75.6  3.51*
M 5 41.0  3.67†
BM 5 51.0  8.61†
B indicates peripheral blood; MPB, mobilized peripheral blood;
BM, bone marrow; PBM, growth factor—primed bone marrow
collected on the day of leukapheresis (corresponding sample of
MPB).
Signiﬁcance by paired Student t test: P  .005.
Signiﬁcance by paired Student t test: P  .375.
B&MTncreased from day 0 to day 6 in the PB after growth
actor administration; however, after 6 days, the number
f CD34CXCR4 cells started to decline while the
umber of CD34CXCR4 cells remained high (Table
). By day 7, the ratio was dramatically altered: there
ere 7.3-fold more CXCR4 cells than CXCR4 cells
mong CD34 cells in the PB. This was due to a 51-fold
ncrease in CD34CXCR4 cells and a 3.6-fold increase
n CD34CXCR4 cells as compared with day 0 (before
rowth factor administration). The increase in the abso-
ute number of CD34CXCR4 cells in the PB proba-
ly reﬂected the migration of this cell population from
M, proliferation of the existing CD34CXCR4 cells
ithin the PB, or downregulation of CXCR4 expression
fter growth factor administration. Therefore, we in-
ended to study whether the increase in the absolute
umber of CD34CXCR4 cells in PB was associated
ith a decrease of CD34 cells in the corresponding
ample of BM. We studied 2 additional animals that
eceived SCF and G-CSF for the mobilization of HSC/
PC. We observed 6- and 20-fold increases in the
umber of PB CD34 cells, respectively, in these 2
aboons (Figure 2).When we examined the correspond-
ng BM sample of the same animal, the absolute number
f CD34 cells increased 3-fold after growth factor ad-
inistration in comparison to steady state. This increase
ted with a Decrease in CXCR4 Expression after Growth Factor
CXCR4 (%)
PB MPB
ND 27
60 12
76 29
67 32
ND 22
67.66  6.53§ 24.4  3.5§
umber of cells plated  100.
l blood; MPB indicates mobilized peripheral blood obtained by
able 3. Absolute Number of PB CD34 on the Basis of CXCR4
xpression
ay CD34 CXCR4 /L CD34 CXCR4 /L
0 25 13
3 32 9
6 295 689
7 91 668
20 14 13
B indicates peripheral blood; these data were obtained from a
single animal who received SCF and G-CSF for PBSC mobili-Associa
PB
9.4
1.1
0.2
6.3
3.6
 1.3‡
f the n
als.
ripherazation.
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6n CD34 cells was associated with a corresponding
ncrease in the absolute number of CFC both in the PB
nd BM (Figure 2).
igure 2. The absolute number of CD34 cells in PB and BM
uring steady state (day 0) and after growth factor administration
day 7). The data were obtained from 2 different baboons: PA6660
A) and PA5909 (B). Each bar represents the number of CD34
ells per microliter of bone marrow or peripheral blood (mean 
E) obtained from 2 separate animals.
igure 3. Subpopulations of CD34 bone marrow cells were sor
reviously [16]. Forward and side scatter proﬁles of CD34HoLow/R
hown. Gated live cells on the basis of the gate shown in (A) and (B)
sotype control, the dotted line histogram is an overlay representing
ine histogram is a overlay representing expression of CXCR4 by C
ost quiescent and primitive population in baboons [16]. M1 was set on
86D34HoLow/RhoLow Cells Are Enriched for
XCR4Low/ Cells
To demonstrate the primitiveness of CD34-
XCR4 cells, we studied the expression of CXCR4 by
D34HoLow/RhoLow cells. This cell population pre-
ents a subpopulation of CD34 cells that are quiescent
nd enriched for CAFC during steady-state hematopoi-
sis [16]. A total of 61% of the BM CD34 cells ex-
ressed CXCR4, whereas only 13% of the HoLow/
hoLow cells expressed CXCR4 (Figure 3). Therefore,
5% of CD34HoLow/RhoLow cells lacked surface ex-
ression of CXCR4, which was designated as
XCR4Low/. The mean ﬂuorescence intensity of
XCR4 expression by CD34HoLow/RhoLow cells was
.88, whereas presorted CD34 cells had a mean ﬂuo-
escence intensity of CXCR4 of approximately 1001.
lonogenic Potential of CD34CXCR4 Cells
To demonstrate the functional potential of
D34CXCR4 cells, CD34 cells from BM were
solated ﬂow cytometrically on the basis of CXCR4
xpression (Figure 4) and assayed for their ability to
the basis of Hoechst/rhodamine (Ho/Rho) staining as described
cells (A) and gating on propidium iodide–negative live cells (B) are
esented as histograms (C). The dark ﬁlled histogram represents the
sion of CXCR4 by CD34 cells before sorting, and the continuous
cells sorted ﬂow cytometrically on the basis of HoLow/RhoLow, theted on
hoLow
are pr
expres
D34the basis of isotype control.
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CXCR4 Negative Cells in Mobilized Peripheral Blood
Borm hematopoietic colonies (CFC) in vitro. Then the
FC potential of CD34, CD34CXCR4, and
D34CXCR4 cells was individually determined. In
igure 5, we demonstrate that CD34CXCR4 cells
ontained more than 4-fold more CFC in comparison to
he CXCR population, including more mixed colonies
n the CXCR4 population (P  .025), indicating their
rimitive nature. To further examine the content of
hese cells, we investigated whether CD34CXCR4
ells were also enriched formore primitiveHPCs such as
AFC. CAFC assays were performed in limiting dilu-
ion to estimate the frequency of CAFC. We observed
hat the CD34CXCR4 cells contained 6-fold more
AFC than CD34CXCR4 cells (Figure 6). These
ndings clearly demonstrate that BM CD34CXCR4
ells are more primitive than CD34CXCR4 cells by
irtue of their greater content of assayable CFC and
AFC.
x Vivo Culture of MPB CD34 Cells
The increase of the number of PB CD34-
XCR4 cells after growth factor administration
igure 4. Bone marrow CD34 cells were sorted ﬂow cytome
hycoerythrin is shown in (A), and the cursor lines in the dot
D34CXCR4 and CD34CXCR4 cells are shown in (B).
igure 5. Content of hematopoietic progenitor cells within
D34CXCR4 and CD34CXCR4 cells obtained from steady-
tate baboon bone marrow. The bar graph represents the mean
umber of colonies  SEM assayed in triplicate from 2 different
aboons. d
B&MTould be attributed to 2 possibilities: growth factor
reatment either results in reduction of CXCR4 ex-
ression by CD34 cells or is due to preferential
obilization of CD34CXCR4 cells. To further ex-
mine the role of growth factors on the expression of
XCR4, CD34 cells enriched from MPB or BM
ere cultured in vitro with G-CSF and SCF for 40
ours. On average, 12% of MPB cells were
D34CXCR4 before culture (0 hours), and after
0 hours of incubation, the numbers of CD34 cells
xpressing CXCR4 increased to 46% (P  .05; Table
). One of the representative ﬂow cytometric analyses
f cells cultured ex vivo is shown in Figure 7. These
ata clearly showed that growth factor exposure in
itro resulted in increased expression of CXCR4 by
D34 cells.
PB Cells Are Capable of Engrafting
yeloablated Baboons
When MPB cells mobilized by SCF and G-CSF
ere used as autografts for 2 myeloablated baboons,
he CD34 cells comprising mostly CXCR4 cells
esulted in a rapid pattern of hematopoietic engraft-
on the basis of CXCR4 expression. The isotype for CXCR4
are set according to the isotype control. The sort regions for
igure 6. Distribution of CAFC frequency among different sub-
opulations of marrow CD34 cells based on CXCR4 expression
rom steady-state baboon bone marrow. The bar graph represents
he mean  SEM of the frequency of CAFC obtained from 2trically
plotsifferent animals.
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6ent in comparison to other 2 animals who received
utologous BM grafts (Table 5). Although the grafts
ere not selected, more than 85% of CD34 cells in
BSC grafts were CXCR4, whereas only 41% of
D34 cells in BM grafts were CXCR4 (Table 2).
n addition, we did not observe any signiﬁcant differ-
nce in the stability of engraftment over 60 to 100
ays after transplantation in animals receiving either
he MPB or BM grafts (data not shown). Despite a
reater absolute number of CD34CXCR4 cells per
able 4. Ex Vivo Culture of CD34 Cells Results in an Increase of
XCR4 Expression
Tissue
CD34CXCR4 (%)
0 h 40 h*
PB† 12.0 44.0
PB 22.0 44.0
PB 3.0 37.0
PB 11.0 59.0
ean  SE 12.0  11.58‡ 46.0  4.64‡
MPB CD34 cells were cultured ex vivo in the presence of SCF and
G-CSF for 40 h.
This animal was mobilized with SCF and G-CSF; all other cases shown
here were mobilized with G-CSF alone.
Paired t test; P  .005.
igure 7. CD34MPB and BM cells were cultured ex vivo in media
upplemented with FBS containing G-CSF and SCF for 40 hours
nd examined ﬂow cytometrically for expression of CXCR4 on
D34 cells. MPB cells are shown before (A) and after (B) culture.
C) BM before culture; (D) BM CD34 cells after culture. The
ursor line on the dot plot was placed on the basis of matched
sotype control. The percentage of each subpopulation of cells isPhown in each quadrant.
88ilogram body weight in BM grafts, MPB grafts en-
rafted faster. Indeed, the possibility of rapid re-ex-
ression of CXCR4 by CD34 cells in vivo after IV
dministration in baboons cannot be ruled out, be-
ause after ex vivo exposure to growth factors, MPB
D34 cells had an increase in the number of CD34
ells coexpressing CXCR4.
ISCUSSION
MPB is increasingly being used as a source of
SC grafts in humans [15]. Rapid engraftment of
ematopoietic cells after PBSC transplantation has
een well documented [24,25]. The interaction be-
ween chemokines and their receptors has been
hought to play a role in stem cell engraftment. It has
lready been shown that HSC/HPC, including
D34 cells, express CXCR4, which binds to its li-
and SDF-1, expressed by BM stromal cells [12]. The
nalysis of CXCR4 in MPB CD34 cells has been
eported by several laboratories with variable results
11,13,14]. In this study, we have shown that in steady
tate, BM CD34CXCR4 cells are the most quies-
ent and highly enriched for both primitive (CAFC)
nd more differentiated (CFC) hematopoietic progen-
tors. In addition, CD34 cells in PB after growth
actor administration are enriched for HPCs in com-
arison to steady-state PB. Our ﬁndings clearly dem-
nstrate that this increase in clonogenic cells in the PB
s associated inversely with the number of cells ex-
ressing CXCR4. The kinetics of CXCR4 expression
n PB MNC after an environmental stimulus (growth
actors) in a clinically relevant large-animal model
upport the observation that CXCR4 expression by
D34 cells is a dynamic process. This ﬁnding is
onsistent with others with a murine model [14].
hese CD34CXCR4 cells are more abundant in
he steady-state BM as compared with steady-state
able 5. Hematopoietic Engraftment after Transplantation of MPB
nd BM
Animal
Day of Recovery after Transplantation
CD34
Cell Dose*
WBC
>1  103/L
Platelets
>20  103/L
A6661† 3.5 10 15
A6243† 2.4 12 16
A6592‡ 21.0 14 21
A6663‡ 6.6 14 21
able 5 is part of previously published data. Reprinted with per-
mission [23].
Expressed as 106 cells per kilogram body weight.
These animals received injections of G-CSF alone to collect the
mobilized peripheral blood (MPB) cell graft.
These animals were not stimulated with growth factors, and bone
marrow (BM) cells were used as a graft.B. A net increase in the absolute number of
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CXCR4 Negative Cells in Mobilized Peripheral Blood
BD34CXCR4 cells in the PB during growth fac-
or–induced mobilization was observed without a net
eduction of the CD34 cell population in the BM.
owever, downregulation of CXCR4 by CD34 cells
fter in vivo growth factor administration is unlikely
ecause ex vivo culture of MPB CD34 cells in the
resence of growth factors resulted in an increase in
he number of CD34CXCR4 cells. These ﬁndings
re consistent with an earlier observation that expo-
ure of CD34 cells to growth factors results in
reater CXCR4 expression [10]. These ﬁndings led us
o examine whether CD34CXCR4 cells are rela-
ively more primitive as compared with a
D34CXCR4 population of cells. In vitro clono-
enic assays provided evidence that marrow
D34CXCR4 cells are enriched for both primitive
nd more differentiated HSC/HPC in vitro. This is
onsistent with the ﬁnding of others showing that
XCR4 cord blood cells are capable of engrafting
nd producing multiple hematopoietic lineages when
ransplanted into the NOD/SCID mouse model [13].
urthermore, in agreement with our hypothesis, Ishii
t al. [26] have shown that human CD34CXCR4
ells from BM were completely devoid of myeloid,
rythroid, megakaryocytic, and mixed CFCs yet pos-
essed the potential to differentiate into lymphoid
ells. These studies indicate that CXCR4 cells are
ctually committed lymphoid progenitors. By con-
rast, the same group showed that marrow
D34CXCR4 cells possess multilineage differen-
iative potential in vitro, suggesting that this cell pop-
lation might resemble an HSC [26]. This group,
owever, did not perform an assay for more primitive
rogenitors (CAFC) but did demonstrate that
D34CXCR4 cells could be generated from
D34CXCR4 cells, indicating the likelihood that
D34CXCR4 cells are more primitive than
D34CXCR4 cells [26]. Therefore, the strategy
uggested by others performing ex vivo culture to
ncrease CXCR4 expression in vitro to enhance their
oming potential warrants more careful evaluation
ecause the expression of CXCR4 in our study is
ssociated with differentiation of primitive HSC/HPC
10]. Furthermore, ex vivo cultured hematopoietic
rafts have had limited engraftment potential because
f discordance between phenotype and function with
he lack of true expansion of engraftable cells [21,27].
We have previously demonstrated that baboon
D34HoLow/RhoLow cells represent a quiescent
rimitive CD34 cell subpopulation [16]. In our cur-
ent study, adult baboon CD34HoLow/RhoLow mar-
ow cells contained the highest number of
D34CXCR4Low/ cells during steady-state hema-
opoiesis. Our ﬁndings also suggest that growth fac-
ors possess the ability to mobilize the most primitive
arrow CD34CXCR4 cells to the PB from the BM
f baboons. In our studies, G-CSF was capable of
B&MTesulting in an increase in the absolute number of
D34CXCR4 relatively primitive cells in the PB.
t is interesting to note that Ishii et al. [26] observed
hat CD34CXCR4 cells expressed the receptor for
-CSF by reverse transcription-polymerase chain
eaction but that CD34CXCR4 cells did not.
hese ﬁndings support the hypothesis that the
D34CXCR4 primitive population is possibly a
ore speciﬁc target population for G-CSF containing
obilizing regimens. Our ﬁndings demonstrate that
D34 cells that do not express CXCR4 are relatively
ore primitive and remain capable of mobilizing to
he PB after growth factor administration. These data
uggest that expression of CXCR4 by CD34 cells is
consequence of differentiation and that the role of
his chemokine receptor in stem cell homing requires
urther investigation.
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